Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper. - EPA | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
EPA
2025
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.
Document
Analyser ce document
